Your browser doesn't support javascript.
loading
Exome sequencing identifies PD-L2 as a potential predisposition gene for lymphoma.
Shao, Jianming; Gao, Lei; Leung, Marco L; Gallinger, Bailey; Inglese, Cara; Meyn, M Stephen; Del Gaudio, Daniela; Das, Soma; Li, Zejuan.
Affiliation
  • Shao J; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA.
  • Gao L; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA.
  • Leung ML; Department of Human Genetics, The University of Chicago, Chicago, Illinois, USA.
  • Gallinger B; The Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.
  • Inglese C; Departments of Pathology and Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA.
  • Meyn MS; Cancer Genetics Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Del Gaudio D; Cancer Genetics Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Das S; Cancer Genetics Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Li Z; Center for Human Genomics and Precision Medicine, University of Wisconsin, Madison, Wisconsin, USA.
Hematol Oncol ; 40(3): 475-478, 2022 Aug.
Article in En | MEDLINE | ID: mdl-35613340

Full text: 1 Database: MEDLINE Main subject: B7-H1 Antigen / Programmed Cell Death 1 Ligand 2 Protein / Lymphoma Limits: Humans Language: En Journal: Hematol Oncol Year: 2022 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: B7-H1 Antigen / Programmed Cell Death 1 Ligand 2 Protein / Lymphoma Limits: Humans Language: En Journal: Hematol Oncol Year: 2022 Type: Article Affiliation country: United States